← SynDRA
BUNAZOSIN
SynDRA canonical compound SYN0005766 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | ADRA1A |
| Mechanism of action | adrenergic receptor antagonist |
| Indication | glaucoma | intraocular pressure |
| Disease area | ophthalmology |
All known targets
- ADRA1A
- ADRA1B
- ADRA1D
- ADRA2B
- NQO2
Mechanisms of action (all sources)
- ADRA1A ANTAGONIST
- Adrenergic receptor alpha-1 antagonist
- ADRA1D ANTAGONIST
- ADRA1B ANTAGONIST
- adrenergic receptor antagonist
- ADRA1D MODULATOR
Drug classes
- Adrenergic Agents
- Adrenergic alpha-1 Receptor Antagonists
- Adrenergic alpha-Antagonists
- Adrenergic Antagonists
- Neurotransmitter Agents
Cross-references
Synonyms
- bunazosin hydrochloride
- detantol
- bunazosin HCl
- Bunazosine
- Bunazosina
- Andante
- E 015
- DE-070
- Detantol-R
- E-1015
- E-643
- Bunazosinum
- 9UUW4V7G2H
- bunazocine
- RefChem:121901
- DTXCID602700
- Bunazosin [INN]
- Bunazosin (INN)
- Bunazosine [French]
- Bunazosinum [Latin]
- Bunazosina [Spanish]
- SR-01000945226
- NCGC00183272-01
- UNII-9UUW4V7G2H
- C19H27N5O3
- BUNAZOSIN [MI]
- BUNAZOSIN [WHO-DD]
- SCHEMBL49348
- MLS006011493
- orb1685215
- SCHEMBL29456750
- SCHEMBL29750637
- CHEBI:135576
- BDBM50088386
- EBC-14148
- MFCD00865793
- AKOS030228613
- AS-73224
Look up BUNAZOSIN in the interactive SynDRA portal →